Grown Rogue (CSE:GRIN) announces the launch of GRAM, an affordable value marijuana brand that promises quality cannabis among the most competitively priced in the market.


The newest brand in the Grown Rogue portfolio, GRAM, is designed with the budget cannabis consumer in mind. GRAM provides simple packaging and capitalizes on internal economies of scale to offer great products at an affordable price. Obie Strickler, CEO and co-founder of Grown Rogue commented on the origin of GRAM, “Our team evaluated demographics of the consumer as well as certain market conditions and realized a high quality, price effective product line in the market-place would be well received.” GRAM currently offers strain-specific flower, pre-rolls, and concentrates. GRAM anticipates expanding the product offering to cartridges and edibles later this year.

Strickler added, “GRAM flower products are primarily produced from outdoor grown flower to maintain the most competitive price points. The majority of the flower sold under the GRAM brand is sourced from quality outdoor cultivation farms in Southern Oregon that we have thoroughly vetted. The result is product cannabinoid profiles that rival indoor production while having a superior terpene profile. GRAM customers gain the benefits of better tasting and smelling flower at lower prices.”

GRAM products are currently offered in one ½ gram or two ½ gram pre-rolled joint containers, or a single full gram joint per container. These options enable GRAM to reach a number of different consumers by providing the exact right product based on their needs. All pre-roll flower is sourced directly from the farmer, and “meticulously crafted with just the right length of crutch and tightness of the roll to ensure a clean and smooth draw when smoking,” Strickler said.

GRAM concentrates are sourced from a variety of state licensed processing companies in Oregon. Currently, the expansion of the GRAM product line is primarily focused on shatter products but will also be offering wax and pull and snap in the future.

Intake Manager Chris Pharis at Club Sockeye – one of Grown Rogue’s dispensary partners says, “We can’t keep those GRAM pre-rolls on the shelves. We have customers coming in asking for them by name. Speaking of that, can I get another order?”

GRAM’s most recent product is a dark chocolate carefully infused with THC/CBD and delicately finished with best-iValun-class standards through Grown Rogue’s partnership with world renowned chocolatier, Lillie Belle. More on this chocolate partnership news will be released in late September. For now, the company proudly presents this photo to whet your appetite.

Currently GRAM is only available in the Oregon market but will be expanding into new states as part of the full-service product offering provided by Grown Rogue and Rogue Distribution. Dispensaries who are interested in carrying GRAM should contact Dave Aldersebaes:

About Grown Rogue
Grown Rogue is a multi-state (Oregon and California) seed-to-experience cannabis brand. The entrepreneurial husband and wife team of Obie and Sarah Strickler shifted a 12 year medical company into Grown rogue to provide premiere cannabis to the Pacific northwest. Grown Rogue products are categorized according to desired user experiences: Relax, Optimize, Groove, Uplift and Energize. The cannabis brand’s line offers flower, pre-rolls and extracts including shatter, wax, oil and sugar. To provide customers with “The Right Experience, Every Time.”™, Grown Rogue grows only the finest cannabis at two wholly owned outdoor facilities and one state of the art 17,000 sq.ft. indoor grow operation, utilizing organic farming practices and meeting all Clean Green Certified standards. The Company also sources high quality flower from Phylos Certified cultivars. The Company’s wholly-owned subsidiary, Rogue Distribution, is the exclusive Microsoft partner in Oregon for the 365 Cannabis™ seed-to-sale ERP software solution powered by Microsoft Dynamics. Rogue Distribution is expanding this ERP model in other states to provide the sophistication, scalability, and security of a fully compliant Cannabis business process & POS system to improve transparency and efficiency to the entire cannabis supply chain. For more information, visit

Grown Rogue is pursuing a public listing. Investors can register for updates at

Media and Logos

For full media on Grown Rogue, download media kit:

* Subsequent to this press release, Grown Rogue went public on Nov 26, 2018 under the ticker symbol CSE:GRIN

Click here to connect with Grown Rogue for an Investor Presentation. 


Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less